Evidence map›Paper›PMID 32583612›Full record

ArticleAdvanced healthcare materials2021

Cancer Cell Invasion of Mammary Organoids with Basal-In Phenotype.

Eric Parigoris, Soojung Lee, David Mertz, Madeleine Turner, Amy Y Liu, Jason Sentosa, Sabra Djomehri, Hao Chen Chang, Kathryn Luker, Gary Luker and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Advanced healthcare materials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Contracting scars from fibrin drops.Integrative biology : quantitative biosciences from nano to macro · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Eric ParigorisWallace H. Coulter Department of Biomedical Engineering and The Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology and Emory School of Medicine, Atlanta, GA, 30332, USA.ORCID 0000-0002-7533-2558
Soojung LeeWallace H. Coulter Department of Biomedical Engineering and The Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology and Emory School of Medicine, Atlanta, GA, 30332, USA.
David MertzWallace H. Coulter Department of Biomedical Engineering and The Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology and Emory School of Medicine, Atlanta, GA, 30332, USA.
Madeleine TurnerWallace H. Coulter Department of Biomedical Engineering and The Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology and Emory School of Medicine, Atlanta, GA, 30332, USA.
Amy Y LiuWallace H. Coulter Department of Biomedical Engineering and The Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology and Emory School of Medicine, Atlanta, GA, 30332, USA.
Jason SentosaWallace H. Coulter Department of Biomedical Engineering and The Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology and Emory School of Medicine, Atlanta, GA, 30332, USA.
Sabra DjomehriDepartment of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Hao Chen ChangWallace H. Coulter Department of Biomedical Engineering and The Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology and Emory School of Medicine, Atlanta, GA, 30332, USA.
Kathryn LukerDepartments of Radiology and Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Gary LukerDepartments of Radiology and Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Celina G KleerDepartment of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Shuichi TakayamaWallace H. Coulter Department of Biomedical Engineering and The Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology and Emory School of Medicine, Atlanta, GA, 30332, USA.
Georgia Institute of Technology · USUniversity of Michigan · US

Funding

Role of CCN6 (WISP3) in the Progression and Metastasis of Breast Cancer.R01CA125577 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Celina G Kleer · 2008 to 2026
$5.5M
Environmental Regulation of Cancer Stem Cell Plasticity in MetastasisU01CA210152 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAHANN, JOERG, LUKER, GARY D · 2017 to 2021
$3.6M
Systems Bioengineering of Cancer Cell MigrationR01CA196018 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LINDERMAN, JENNIFER JEAN, LUKER, GARY D · 2015 to 2019
$2.2M
Specialist in Multi-Scale Molecular Imaging of Tumor EnvironmentsR50CA221807 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kathryn Luker · 2018 to 2026
$1.6M
NCI NIH HHS R01 CA125577NCI NIH HHS R01 CA196018NCI NIH HHS R50 CA221807NCI NIH HHS U01 CA210152
6 · The paper itself

Abstract

This paper describes mammary organoids with a basal-in phenotype where the basement membrane is located on the interior surface of the organoid. A key materials consideration to induce this basal-in phenotype is the use of a minimal gel scaffold that the epithelial cells self-assemble around and encapsulate. When MDA-MB-231 breast cancer cells are co-cultured with epithelial cells from day 0 under these conditions, cells self-organize into patterns with distinct cancer cell populations both inside and at the periphery of the epithelial organoid. In another type of experiment, the robust formation of the basement membrane on the epithelial organoid interior enables convenient studies of MDA-MB-231 invasion in a tumor progression-relevant direction relative to epithelial cell-basement membrane positioning. That is, the study of cancer invasion through the epithelium first, followed by the basement membrane to the basal side, is realized in an experimentally convenient manner where the cancer cells are simply seeded on the outside of preformed organoids, and their invasion into the organoid is monitored. Interestingly, invasion is more prominent when tumor cells are added to day 7 organoids with less developed basement membranes compared to day 16 organoids with more defined ones.

Indexed as

Epithelial CellsOrganoidsBasement MembraneHumansNeoplasm InvasivenessPhenotypebasal-in phenotypebasement membranebreast cancerinvasionorganoid

Identifiers

PMID32583612
PMCPMC7759600
OpenAlexW3037739159

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.